AIM AIM ImmunoTech Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $5.7M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $100.0K | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $35.5K | $0 |
| 2023-Q4 | $14.9K | $0 |
| 2024-Q1 | $82.5K | $0 |
| 2024-Q2 | $38.0K | $0 |
| 2024-Q3 | $7.7K | $0 |
| 2024-Q4 | $54.7K | $870 |
| 2025-Q1 | $21.8K | $0 |
| 2025-Q2 | $128.2K | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $13.5K | $0 |
| 2026-Q4 | $31.0K | $0 |
Bought$527.8K40 buy days
Sold$8701 sell day
Net insider flow+$526.9Knet buying · 5 years
Latest trade2026-11-11Equels Thomas K
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-11 | Buy | Equels Thomas K | CEO | 35,000 | $0.15 | $5.2K | 1 |
| 2026-11-10 | Buy | Equels Thomas K | CEO | 39,000 | $0.14 | $5.4K | 1 |
| 2026-11-09 | Buy | Equels Thomas K | CEO | 31,298 | $0.16 | $5.1K | 1 |
| 2026-11-06 | Buy | Equels Thomas K | CEO | 33,050 | $0.16 | $5.2K | 2 |
| 2026-10-23 | Buy | Equels Thomas K | CEO | 31,675 | $0.16 | $5.1K | 1 |
| 2026-10-22 | Buy | Equels Thomas K | CEO | 31,250 | $0.16 | $5.1K | 1 |
| 2026-09-17 | Buy | Equels Thomas K | CEO | 24,000 | $0.21 | $5.0K | 1 |
| 2026-09-16 | Buy | Equels Thomas K | CEO | 11,000 | $0.21 | $2.3K | 1 |
| 2026-09-15 | Buy | Equels Thomas K | CEO | 22,000 | $0.22 | $4.9K | 1 |
| 2026-09-14 | Buy | Equels Thomas K | CEO | 5,900 | $0.22 | $1.3K | 1 |
| 2025-06-13 | Buy | Equels Thomas K | CEO | 107 | $7.70 | $824 | 1 |
| 2025-06-12 | Buy | Equels Thomas K | CEO | 103 | $8.70 | $896 | 1 |
| 2025-04-11 | Buy | KELLNER TED D | Director | 1,968,504 | $0.03 | $59.1K | 1 |
| 2025-04-11 | Buy | Equels Thomas K | CEO | 1,968,504 | $0.03 | $59.1K | 1 |
| 2025-04-11 | Buy | MITCHELL WILLIAM M | Director | 196,851 | $0.03 | $5.9K | 1 |
| 2025-04-04 | Buy | Equels Thomas K | CEO | 41,000 | $0.06 | $2.5K | 1 |
| 2025-04-04 | Buy | Rodino Peter W III | COO | 500 | $0.09 | $45 | 1 |
| 2025-03-05 | Buy | Equels Thomas K | CEO | 50,000 | $0.13 | $6.5K | 1 |
| 2025-03-04 | Buy | Equels Thomas K | CEO | 127,334 | $0.12 | $15.3K | 2 |
| 2024-12-19 | Sell | MITCHELL WILLIAM M | Director | 4,580 | $0.19 | $870 | 1 |
| 2024-12-18 | Buy | Equels Thomas K | CEO | 22,727 | $0.21 | $4.8K | 1 |
| 2024-12-02 | Buy | APPELROUTH STEWART | Director | 11,112 | $0.21 | $2.3K | 2 |
| 2024-11-21 | Buy | Equels Thomas K | CEO | 20,000 | $0.21 | $4.2K | 1 |
| 2024-11-20 | Buy | Equels Thomas K | CEO | 145,110 | $0.19 | $27.8K | 2 |
| 2024-11-20 | Buy | APPELROUTH STEWART | Director | 81,953 | $0.19 | $15.6K | 1 |
| 2024-09-16 | Buy | Equels Thomas K | CEO | 5,000 | $0.30 | $1.5K | 1 |
| 2024-09-13 | Buy | Equels Thomas K | CEO | 20,000 | $0.31 | $6.2K | 1 |
| 2024-05-06 | Buy | Equels Thomas K | CEO | 61,729 | $0.41 | $25.3K | 1 |
| 2024-05-06 | Buy | Rodino Peter W III | COO | 30,865 | $0.41 | $12.7K | 1 |
| 2024-03-21 | Buy | BRYAN NANCY | Director | 38,462 | $0.39 | $15.0K | 1 |
| 2024-03-15 | Buy | APPELROUTH STEWART | Director | 90,910 | $0.33 | $30.0K | 1 |
| 2024-03-15 | Buy | Equels Thomas K | CEO | 75,758 | $0.33 | $25.0K | 1 |
| 2024-03-15 | Buy | Rodino Peter W III | COO | 37,879 | $0.33 | $12.5K | 1 |
| 2023-11-27 | Buy | Equels Thomas K | CEO | 33,861 | $0.44 | $14.9K | 1 |
| 2023-09-29 | Buy | Equels Thomas K | CEO | 22,676 | $0.44 | $10.0K | 1 |
| 2023-08-25 | Buy | Equels Thomas K | CEO | 8,222 | $0.67 | $5.5K | 1 |
| 2023-08-24 | Buy | Equels Thomas K | CEO | 14,993 | $0.67 | $10.0K | 1 |
| 2023-07-17 | Buy | Equels Thomas K | CEO | 16,950 | $0.59 | $10.0K | 1 |
| 2023-01-03 | Buy | Equels Thomas K | CEO | 161,291 | $0.31 | $50.0K | 1 |
| 2023-01-03 | Buy | APPELROUTH STEWART | Director | 80,646 | $0.31 | $25.0K | 1 |
| 2023-01-03 | Buy | Rodino Peter W III | COO | 80,646 | $0.31 | $25.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Equels Thomas K | CEO | $324.7K | $0 | 2026-11-11 |
| APPELROUTH STEWART | Director | $72.9K | $0 | 2024-12-02 |
| KELLNER TED D | Director | $59.1K | $0 | 2025-04-11 |
| Rodino Peter W III | COO | $50.2K | $0 | 2025-04-04 |
| BRYAN NANCY | Director | $15.0K | $0 | 2024-03-21 |
| MITCHELL WILLIAM M | Director | $5.9K | $870 | 2025-04-11 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2025-03-04 → 2025-04-11 | 4 | $148.3K | 49 | – | – | – | closed |
| 2024-03-15 → 2024-03-21 | 4 | $82.5K | 54 | +19.8% (+16.6% raw) | -3.9% (-2.9% raw) | -37.5% (-27.1% raw) | closed |
| 2023-01-03 | 3 | $100.0K | 51 | +31.3% (+44.1% raw) | +10.4% (+10.2% raw) | +62.0% (+68.4% raw) | closed |
| 2019-06-21 → 2019-06-27 | 6 | $274.0K | 61 | -41.4% (-37.8% raw) | -84.1% (-86.4% raw) | -97.0% (-87.3% raw) | closed |
| 2018-07-23 → 2018-07-27 | 4 | $104.1K | 35 | -18.8% (-17.2% raw) | -30.0% (-31.9% raw) | -23.1% (-27.8% raw) | closed |
| 2017-04-11 → 2017-05-02 | 5 | $185.0K | 32 | – | – | – | closed |
| 2017-02-16 | 3 | $11.4K | 12 | – | – | – | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.